Testosterone receptor may be a potential target for triple negative breast cancer

[News]

Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).

More... (http://www.news-medical.net/news/20120326/Testosterone-receptor-may-be-a-potential-target-for-triple-negative-breast-cancer.aspx)